tiprankstipranks
Trending News
More News >
TG Therapeutics (TGTX)
NASDAQ:TGTX

TG Therapeutics (TGTX) Revenue

Compare
2,111 Followers

TG Therapeutics Revenue

TG Therapeutics had a revenue of 161.71M in the quarter ending Sep 30, 2025, with 14.57%. This bring the company's revenue in the last twelve months to 531.90M, Decreased 17.14%. In the fiscal year ending Dec 31, 2024, TG Therapeutics had annual revenue of 329.00M with 40.80% growth.
Revenue (ttm)
531.90M
Revenue Growth
100.88%
P/S Ratio
14.93
Revenue/Employee
$934,670
Employees
352
Market Cap
$4.91B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
329.00M95.34M+140.80%
Dec 31, 2023
233.66M230.88M+8,390.02%
Dec 31, 2022
2.79M-3.90M+41.64%
Dec 31, 2021
6.69M6.54M+4,400.69%
Dec 31, 2020
152.00K0.00+100.00%
Dec 31, 2019
152.00K0.00+100.00%
Dec 31, 2018
152.00K-381.00+99.75%
Dec 31, 2017
152.38K